Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
| Autor: | Krystal, John H, Kane, John M, Correll, Christoph U, Walling, David P, Leoni, Matthew, Duvvuri, Sridhar, Patel, Shrinal, Chang, Ih, Iredale, Philip *, Frohlich, Lillian, Versavel, Stacey, Perry, Pamela, Sanchez, Raymond, Renger, John |
|---|---|
| Zdroj: | In The Lancet 17 December 2022-6 January 2023 400(10369):2210-2220 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|